Occudo Quantitative Strategies’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-12,141
Closed -$58.5K – 971
2026
Q2
$58.5K Buy
+12,141
New +$73.3K ﹤0.01% 741
2024
Q3
– Sell
-6,616
Closed -$398K – 990
2024
Q2
$398K Sell
6,616
-3,203
-33% -$183K 0.07% 361
2024
Q1
$506K Sell
9,819
-21,609
-69% -$1.06M 0.09% 301
2023
Q4
$1.27M Buy
+31,428
New +$922K 0.17% 163
2023
Q3
– Sell
-17,544
Closed -$505K – 1273
2023
Q2
$505K Buy
+17,544
New +$390K 0.05% 555

Other funds holding RXST

Occudo Quantitative Strategies's RXST Position: Q3 2026 in Review

Occudo Quantitative Strategies sold out of RxSight (RXST) in Q3 2026, closing a stake of 12,141 shares — an estimated $58.5K sold.

Occudo Quantitative Strategies first reported a position in RXST in Q2 2023 and held it in 5 quarters. The position peaked at $1.27M in Q4 2023. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Occudo Quantitative Strategies reported no remaining RxSight position as of Q3 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 12,141 RxSight shares in Q3 2026, an estimated $58.5K.
  • Occudo Quantitative Strategies first reported a position in RxSight in Q2 2023 and held it in 5 quarters.
  • Occudo Quantitative Strategies's RxSight position peaked at $1.27M in Q4 2023.
  • 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q3 2026, filed 16 Nov 2026.